The pathophysiology of amenorrhea in the adolescent

Annals of the New York Academy of Sciences

Volumn 1135, Issue , 2008, Pages 163-178

  Golden, Neville H ^a   Carlson, Jennifer L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Amenorrhea

Indexed keywords

AMISULPRIDE; CLOZAPINE; CONTRACEPTIVE AGENT; ESTROGEN; GONADORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; METHYLDOPA; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RECOMBINANT LEPTIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE; ZOTEPINE;

AMENORRHEA; ANDROGEN INSENSITIVITY SYNDROME; ANOREXIA NERVOSA; BONE DENSITY; CHRONIC DISEASE; CLINICAL EVALUATION; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; CRANIOPHARYNGIOMA; CUSHING SYNDROME; EATING DISORDER; ENDOMETRIUM CARCINOMA; EXERCISE; FRACTURE; GONADAL DYSGENESIS; GONADOTROPIN DEFICIENCY; HUMAN; HYMEN; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHYROIDISM; KALLMANN SYNDROME; LONG TERM CARE; MENARCHE; MENSTRUAL CYCLE; MENTAL STRESS; METRORRHAGIA; MORBIDITY; NONHUMAN; OVARY DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIMARY AMENORRHEA; PROLACTINOMA; RISK FACTOR; SECONDARY AMENORRHEA; SIDE EFFECT; TESTICULAR FEMINIZATION; UTERINE CERVIX DISEASE; UTERUS BLEEDING; UTERUS SYNECHIA; VAGINA APLASIA;

EID: 45549104193     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1429.014     Document Type: Conference Paper

References (82)

1. Chumlea, W.C., C.M. Schubert, A.F. Roche, et al. 2003. Age at menarche and racial comparisons in US girls. Pediatrics 111 : 110 113.
2. Diaz, A., M.R. Laufer & L.L. Breech. 2006. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 118 : 2245 2250.
3. Herman-Giddens, M.E., E.J. Slora, R.C. Wasserman, et al. 1997. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 99 : 505 512.
4. Kaplowitz, P.B., E.J. Slora, R.C. Wasserman, et al. 2001. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 108 : 347 353.
5. Wang, Y. 2002. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 110 : 903 910.
6. Golden, N.H. & I.R. Shenker. 1992. Amenorrhea in anorexia nervosa: etiology and implications. Adolesc. Med. 3 : 503 518.
7. Ropert, J.F., M.E. Quigley & S.S. Yen. 1984. The dopaminergic inhibition of LH secretion during the menstrual cycle. Life Sci. 34 : 2067 2073.
8. Apter, D. 1997. Development of the hypothalamic-pituitary-ovarian axis. Ann. N.Y. Acad. Sci. 816 : 9 21.
9. Boyar, R.M., R.S. Rosenfeld, S. Kapen, et al. 1974. Human puberty: simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J. Clin. Invest. 54 : 609 618.
10. Slap, G.B. 2003. Menstrual disorders in adolescence. Best Pract. Res. Clin. Obstet.Gynaecol. 17 : 75 92.
11. Biro, F.M., B. Huang, P.B. Crawford, et al. 2006. Pubertal correlates in black and white girls. J. Pediatr. 148 : 234 240.
12. Sun, S.S., C.M. Schubert, W.C. Chumlea, et al. 2002. National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 110 : 911 919.
13. Wiksten-Almstromer, M., A.L. Hirschberg & K. Hagenfeldt. 2007. Menstrual disorders and associated factors among adolescent girls visiting a youth clinic. Acta Obstet. Gynecol. Scand. 86 : 65 72.
14. Perkins, R.B., J.E. Hall & K.A. Martin. 2001. Aetiology, previous menstrual function and patterns of neuro-endocrine disturbance as prognostic indicators in hypothalamic amenorrhoea. Hum. Reprod. 16 : 2198 2205.
15. Eckert, E.D., C. Pomeroy, N. Raymond, et al. 1998. Leptin in anorexia nervosa. J. Clin. Endocrinol. Metab 83 : 791 795.
16. Grinspoon, S., T. Gulick, H. Askari, et al. 1996. Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab 81 : 3861 3863.
17. Haas, V., S. Onur, T. Paul, et al. 2005. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am. J. Clin. Nutr. 81 : 889 896.
18. Misra, M., K.K. Miller, C. Almazan, et al. 2004. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J. Clin. Endocrinol. Metab 89 : 3486 3495.
19. Katzman, D.K., N.H. Golden, D. Neumark-Sztainer, et al. 2000. From prevention to prognosis: clinical research update on adolescent eating disorders. Pediatr. Res. 47 : 709 712.
20. Holtkamp, K., C. Mika, I. Grzella, et al. 2003. Reproductive function during weight gain in anorexia nervosa: leptin represents a metabolic gate to gonadotropin secretion. J. Neural Transm. 110 : 427 435.
21. Thong, F.S., C. McLean & T.E. Graham. 2000. Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors. J. Appl. Physiol. 88 : 2037 2044.
22. Weimann, E., W.F. Blum, C. Witzel, et al. 1999. Hypoleptinemia in female and male elite gymnasts. Eur. J. Clin. Invest. 29 : 853 860.
23. Welt, C.K., J.L. Chan, J. Bullen, et al. 2004. Recombinant human leptin in women with hypothalamic amenorrhea. N. Engl. J. Med. 351 : 987 997.
24. Hoek, H.W. & D. van Hoeken. 2003. Review of the prevalence and incidence of eating disorders. Int. J. Eat. Disord. 34 : 383 396.
25. Lucas, A.R., C.S. Crowson, W.M. O'Fallon & L.J. Melton. 1999. The ups and downs of anorexia nervosa. Int. J. Eat. Disord. 26 : 397 405.
26. Frisch, R.E. & J.W. McArthur. 1974. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185 : 949 951.
27. Golden, N.H., M.S. Jacobson, J. Schebendach, et al. 1997. Resumption of menses in anorexia nervosa. Arch. Pediatr. Adolesc. Med. 151 : 16 21.
28. Katzman, D.K. & N.H. Golden. 2007. Anorexia nervosa and bulimia nervosa. In Adolescent Healthcare: A Practical Guide, 5th ed. L.S. Neinstein, Ed. Lippincott Williams & Wilkins. Philadelphia, PA.
29. Frisch, R.E., A.V. Gotz-Welbergen, J.W. McArthur, et al. 1981. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA 246 : 1559 1563.
30. Warren, M.P. & N.E. Perlroth. 2001. The effects of intense exercise on the female reproductive system. J. Endocrinol. 170 : 3 11.
31. Nichols, J.F., M.J. Rauh, M.J. Lawson, et al. 2006. Prevalence of the female athlete triad syndrome among high school athletes. Arch. Pediatr. Adolesc. Med. 160 : 137 142.
32. Russell, J.B., D. Mitchell, P.I. Musey & D.C. Collins. 1984. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet. Gynecol. 63 : 452 456.
33. Loucks, A.B., M. Verdun & E.M. Heath. 1998. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J. Appl. Physiol. 84 : 37 46.
34. Miller, K.K., M.S. Parulekar, E. Schoenfeld, et al. 1998. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J. Clin. Endocrinol. Metab. 83 : 2309 2312.
35. Constantini, N.W. & M.P. Warren. 1995. Menstrual dysfunction in swimmers: a distinct entity. J. Clin. Endocrinol. Metab. 80 : 2740 2744.
36. Thangavelu, K. & S. Geetanjali. 2006. Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications. Exp. Clin. Psychopharmacol. 14 : 459 460.
37. Wieck, A. & P.M. Haddad. 2003. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br. J. Psychiatry 182 : 199 204.
38. Magiakou, M.A., G. Mastorakos, E. Webster & G.P. Chrousos. 1997. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann. N.Y. Acad. Sci. 816 : 42 56.
39. Genazzani, A.D., O. Gamba, L. Sgarbi, et al. 1997. Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty. Ann. N.Y. Acad. Sci. 816 : 76 82.
40. Neinstein, L.S., D. Stewart, C.I. Wang & I. Johnson. 1983. Menstrual dysfunction in cystic fibrosis. J. Adolesc. Health Care 4 : 153 157.
41. Platt, O.S., W. Rosenstock & M.A. Espeland. 1984. Influence of sickle hemoglobinopathies on growth and development. N. Engl. J. Med. 311 : 7 12.
42. Rosmark, B., C. Berne, S. Holmgren, et al. 1986. Eating disorders in patients with insulin-dependent diabetes mellitus. J. Clin. Psychiatry 47 : 547 550.
43. Jones, J.M., M.L. Lawson, D. Daneman, et al. 2000. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. Br. Med. J. 320 : 1563 1566.
44. Rydall, A.C., G.M. Rodin, M.P. Olmsted, et al. 1997. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N. Engl. J. Med. 336 : 1849 1854.
45. Stead, R.J., M.E. Hodson, J.C. Batten, et al. 1987. Amenorrhoea in cystic fibrosis. Clin. Endocrinol. (Oxf.) 26 : 187 195.
46. Snajderova, M., J. Martinek, J. Horejsi, et al. 1999. Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J. Pediatr. Adolesc. Gynecol. 12 : 209 214.
47. Schaefer, F., G. Hamill, R. Stanhope, et al. 1991. Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. J. Pediatr. 119 : 568 577.
48. Seminara, S.B., F.J. Hayes & W.F. Crowley. 1998. Gonadotropin- releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev. 19 : 521 539.
49. Patel, S.S. & V. Bamigboye. 2007. Hyperprolactinaemia. J. Obstet. Gynaecol. 27 : 455 459.
50. Pickett, C.A. 2003. Diagnosis and management of pituitary tumors: recent advances. Prim. Care 30 : 765 789.
51. Brenner, S.H., J.B. Lessing, J. Quagliarello & G. Weiss. 1985. Hyperprolactinemia and associated pituitary prolactinomas. Obstet. Gynecol. 65 : 661 664.
52. Trarbach, E.B., L.G. Silveira & A.C. Latronico. 2007. Genetic insights into human isolated gonadotropin deficiency. Pituitary 10 : 381 391.
53. Karavitaki, N., S. Cudlip, C.B. Adams & J.A. Wass. 2006. Craniopharyngiomas. Endocr. Rev. 27 : 371 397.
54. Krassas, G.E. 2000. Thyroid disease and female reproduction. Fertil. Steril. 74 : 1063 1070.
55. Koutras, D.A. 1997. Disturbances of menstruation in thyroid disease. Ann. N.Y. Acad. Sci. 816 : 280 284.
56. Raber, W., A. Gessl, P. Nowotny & H. Vierhapper. 2003. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin. Endocrinol. (Oxf.) 58 : 185 191.
57. Newfield, R.S. & M.I. New. 1997. 21-Hydroxylase deficiency. Ann. N.Y. Acad. Sci. 816 : 219 229.
58. Speiser, P.W. & P.C. White. 2003. Congenital adrenal hyperplasia. N. Engl. J. Med. 349 : 776 788.
59. Moran, C., R. Azziz, E. Carmina, et al. 2000. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am. J. Obstet. Gynecol. 183 : 1468 1474.
60. Klingensmith, G.J., A.C. Wentz, W.J. Meyer & C.J. Migeon. 1976. Gonadotropin output in congenital adrenal hyperplasia before and after adrenal suppression. J. Clin. Endocrinol. Metab. 43 : 933 936.
61. Driscoll, D.A. 2003. Polycystic ovary syndrome in adolescence. Ann. N.Y. Acad. Sci. 997 : 49 55.
62. Michelmore, K.F., A.H. Balen, D.B. Dunger & M.P. Vessey. 1999. Polycystic ovaries and associated clinical and biochemical features in young women. Clin. Endocrinol.(Oxf.) 51 : 779 786.
63. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81 : 19 25.
64. Dunaif, A. & D.T. Finegood. 1996. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab 81 : 942 947.
65. Gilling-Smith, C., H. Story, V. Rogers & S. Franks. 1997. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 47 : 93 99.
66. Ehrmann, D.A., R.B. Barnes & R.L. Rosenfield. 1995. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 16 : 322 353.
67. Moran, C., R. Reyna, L.S. Boots & R. Azziz. 2004. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil. Steril. 81 : 126 131.
68. Pastor, C.L., M.L. Griffin-Korf, J.A. Aloi, et al. 1998. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab 83 : 582 590.
69. Kaufman, F.R., M.D. Kogut, G.N. Donnell, et al. 1981. Hypergonadotropic hypogonadism in female patients with galactosemia. N. Engl. J. Med. 304 : 994 998.
70. Kaufman, F.R., G.N. Donnell, T.F. Roe & M.D. Kogut. 1986. Gonadal function in patients with galactosaemia. J. Inherit. Metab. Dis. 9 : 140 146.
71. Boehmer, A.L., O. Brinkmann, H. Bruggenwirth, et al. 2001. Genotype versus phenotype in families with androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 86 : 4151 4160.
72. Varner, R.E., J.B. Younger & R.E. Blackwell. 1985. Mullerian dysgenesis. J. Reprod. Med. 30 : 443 450.
73. Edmonds, D.K. 2000. Congenital malformations of the genital tract. Obstet. Gynecol. Clin. North Am. 27 : 49 62.
74. Golden, N.H. 2003. Osteopenia and osteoporosis in anorexia nervosa. Adolesc. Med. 14 : 97 108.
75. Grinspoon, S., K. Miller, C. Coyle, et al. 1999. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J. Clin. Endocrinol. Metab 84 : 2049 2055.
76. Vestergaard, P., C. Emborg, R.K. Stoving, et al. 2002. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders-a nationwide register study. Int. J. Eat. Disord. 32 : 301 308.
77. Golden, N.H., L. Lanzkowsky, J. Schebendach, et al. 2002. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J. Pediatr. Adolesc. Gynecol. 15 : 135 143.
78. Golden, N.H. 2007. Eating disorders in adolescence: what is the role of hormone replacement therapy? Curr. Opin. Obstet. Gynecol. 19 : 434 439.
79. Klibanski, A., B.M. Biller, D.A. Schoenfeld, et al. 1995. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J. Clin. Endocrinol. Metab. 80 : 898 904.
80. Strokosch, G.R., A.J. Friedman, S.C. Wu & M. Kamin. 2006. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J. Adolesc. Health 39 : 819 827.
81. Cromer, B.A., M. Stager, A. Bonny, et al. 2004. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J. Adolesc. Health 35 : 434 441.
82. Cromer, B.A., D. Scholes, A. Berenson, et al. 2006. Depot medroxyprogesterone acetate and bone mineral density in adolescents-the black box warning: a position paper of the Society for Adolescent Medicine. J. Adolesc. Health 39 : 296 301.